trending Market Intelligence /marketintelligence/en/news-insights/trending/oimyryhryiv9evmlnz1zdg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Mersana adds former Amgen exec to board

Blog

Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021


Mersana adds former Amgen exec to board

Cambridge, Mass.-based Mersana Therapeutics Inc. appointed Willard Dere as an independent director of the company.

Dere, who is a professor at the University of Utah Health Sciences Center, has over three decades of research, clinical and regulatory biopharmaceutical leadership experience. He is the former chief medical officer of Amgen and has also served Eli Lilly and Co. in a number of leadership positions, Mersana said in a statement.